CFM
CDLX icon

Catalyst Funds Management’s Cardlytics CDLX Stock Holding History

Catalyst Funds Management’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,960
Closed -$32.2K – 514
2025
Q2 		$32.2K Buy
+1,960
New +$33.8K 0.01% 399

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Catalyst Funds Management's CDLX Position: Q3 2025 in Review

Catalyst Funds Management sold out of Cardlytics (CDLX) in Q3 2025, closing a stake of 1,960 shares — an estimated $32.2K sold.

Catalyst Funds Management first reported a position in CDLX in Q2 2025 and held it in 1 quarter. The position peaked at $32.2K in Q2 2025. 81 funds tracked by Wall St. Rank hold CDLX as of Q3 2025.

  • Catalyst Funds Management reported no remaining Cardlytics position as of Q3 2025 after selling out during the quarter.
  • Catalyst Funds Management sold 1,960 Cardlytics shares in Q3 2025, an estimated $32.2K.
  • Catalyst Funds Management first reported a position in Cardlytics in Q2 2025 and held it in 1 quarter.
  • Catalyst Funds Management's Cardlytics position peaked at $32.2K in Q2 2025.
  • 81 funds tracked by Wall St. Rank held Cardlytics as of Q3 2025.

Based on Catalyst Funds Management's 13F filing for Q3 2025, filed 12 Nov 2025.